Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDIA6 | Q15084 | 1/20 | 0.53 |
| ▸ | THRA | P10827 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 3/20 | 0.46 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6741835 | 1.00 | PDIA6 (0.53) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL385151 | 1.00 | PDIA6 (0.53) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL6739637 | 1.00 | PDIA6 (0.53) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL6736812 | 1.00 | PDIA6 (0.53) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL30667567 | 1.00 | PDIA6 (0.53) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL6738526 | 1.00 | PDIA6 (0.53) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL6743631 | 1.00 | PDIA6 (0.53) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL6740264 | 0.99 | PDIA6 (0.55) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL6741158 | 0.96 | PDIA6 (0.54) | PDIA6THRATHRBNR5A1TP53 | |
| SCHEMBL6741894 | 0.88 | PDIA6 (0.41) | PDIA6NR5A1TP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6689530-B2 | ULTRAVIOLET LITHOGRAPHY MICROFABRICATION WITH IMPROVED RESOLUTION AND PATTERN PROFILE AFTER DEVELOPMENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-02-10 | — | — | US | disclosed |
| US-20030180653-A1 | Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180653-A1 | Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process | CACNA1A, KCNA1, POLL | PDIA6 2603/4885THRA 4108/4885THRB 4655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.